Ranked as one of Americas best in cancer care by U.S.News & World Report, including our top rankings in digestive disorders, urology and neurology. Over.

Ranked as one of America’s best in cancer care by U.S.News & World Report, including our top rankings in digestive disorders, urology and neurology.

Over 250 cancer specialists and researchers

More than 350 active cancer clinical trials

Annually serves more than 26,000 cancer patients

Taussig Cancer Institute Strengths

Nationally recognized staff

Multi-disciplinary clinics

Translational research efforts

Educational programs

State-of-the-art technology

“We have entered into a very dynamic period in oncology with breathtaking developments in our understanding of the basic biology of cancer and a dramatic increase in the number of novel anticancer agents. 

The job going forward is to integrate translational science and clinical research with optimal and compassionate patient care.”

Robert Dreicer, MD

Chairman, Department of Solid Tumor Oncology

Did you know?

Our multidisciplinary clinic for GI cancer incorporates close collaboration with a number of departments including:

Gastroenterology Colorectal Surgery Interventional Radiology Radiation Oncology

Patients are offered a wide variety of clinical trials, ranging from large randomized trials sponsored by the NCI to Cleveland Clinic local trials of experimental drugs.

“The Renal Cell Carcinoma Program at the Cleveland Clinic Taussig Cancer Institute is a recognized international leader that provides best in class multidisciplinary care of kidney cancer patients.

In conjunction with the Glickman Urological and Kidney Institute, the program has played a critical role in the development of practice-changing novel therapy.

We will continue to innovate through translational clinical trials that advance both the science of kidney cancer and the clinical care of patients.”

Brian Rini, MD

Department of Solid Tumor Oncology

Fully Certified Staff

Physicians are board-certified in Therapeutic Radiology by the American Board of Radiology

Senior medical physicists are certified by the American Board of Radiology and/or the American

Board of Medical Physics

Therapist staff are certified by the American Registry of Radiologic Technologists

Registered nursing staff are certified by the Oncology Nursing Society

Dosimetrists are certified by the Medical Dosimetrist Certification Board

“Lung cancer is managed by a team of experts, including medical and radiation oncologists, thoracic surgeons, and pulmonary physicians who work hand in hand.

We focus on innovative multidisciplinary approaches for the treatment of lung cancer.”

Tarek Mekhail, MD

Department of Solid Tumor Oncology

Cancer Consult

An Update for Physicians from Cleveland Clinic Taussig Cancer Institute

Includes articles on the latest advances inbasic science and clinical research.

Recent articles include:

The State of Myelodysplastic Syndrome (MDS) Treatment

G1P3 Antagonizes TRAIL-induced Apoptosis in Human Myeloma Cells

Translating Acute Leukemia Research from Bench-to-Bedside

"We have entered the era of molecular targeting in cancer therapy. Optimal management of the disease requires an intimate knowledge of cancer biology and therapeutic targets, the development of creative ways of delivering drugs to those targets, and well-trained research oriented clinicians dedicated to providing cutting edge therapy."

Timothy Spiro, MD

Chair, Department of Regional Oncology

Physicians and researchers in the Taussig Cancer Institute pioneered the use of early chemotherapy after initial surgery to improve cure rates in bladder and prostate cancer.

They also have developed novel anti-cancer drugs for patients with cancers of the prostate, bladder, testes, kidney and other tumors of the genitourinary system.

Did you know?

“We understand the importance of research and innovation in delivering the most current and best medical care to individuals with leukemia, lymphoma, and other hematological malignancies, but never lose sight of the fact that clinical excellence and compassion is our primary mission.”

Brian Bolwell, MD

Chairman,  Department of Hematologic Oncology and Blood Disorders

“The Center for Hematology Oncology and Molecular Therapeutics at the Taussig Cancer Institute is investigating targeted therapies that will be helpful in improving treatments for renal carcinoma.  

This research extends advances made in clinical use of growth factor receptor inhibitors for renal carcinoma.”

Ernest Borden, MD

Department of Solid Tumor Oncology

“The real advantage of Gamma Knife®

radiosurgery compared to traditional surgery is that patients can go on with their lives. For a patient with cancer that is very important.”

John Suh, MDChairman, Department of Radiation Oncology

Did you know?

Recently Taussig Cancer Institute introduced a Late Effects Clinic for cancer survivors.

This multidisciplinary clinic helps to address health problems that can arise as late effects of successful cancer treatment.

“At Cleveland Clinic all patients with head and neck cancer are approached by a multidisciplinary team from head and neck surgery, radiation and medical oncology, dentistry, speech pathology, physical therapy and dietary services. 

Aggressive, cutting-edge treatments, many developed at Cleveland Clinic, have led to successful organ preservation and cure in the vast majority of patients with these formerly devastating malignancies."

David Adelstein, MD

Department of Solid Tumor Oncology

Visit us on the web: Visit us on the web: www.clevelandclinic.org/cancer

Get up-to-date information from Cleveland Clinic right from your computer.

Learn about some of the latest innovations and techniques from the Taussig Cancer Institute.

View recent physician publications.

“The science of palliative and supportive therapies is integral to the advancement of anti-tumor therapies. Without them many of the present day advances would not be possible.

Research in symptom management and supportive care is equally important now, because patients are living longer as a result of disease modifying chemotherapy, targeted tyrosine kinase inhibitors and monoclonal antibodies.”

Mellar Davis, MD

Department of Solid Tumor Oncology

In our multidisciplinary clinics, subspecialists bring their expertise to bear on specific tumor types and aspects of treatment and recovery.

Medical, surgical and radiationoncologists collaborate closely with pathologists, radiologists, oncology nurses and social workers. These interactions enhance effective communication and optimize the options for individual patients with complex problems.

Did you know?

“At Cleveland Clinic we seek to individualize the treatment of breast cancer patients, based on sound scientific research.

Patients are offered state-of-the-art and investigational therapies based on their individual tumor's biology.”

G. Thomas Budd, MD

Department of Solid Tumor Oncology

Cleveland Clinic is consistently ranked

as one of America’s top hospitals

by U.S.News & World Report

"The cutting edge is an effective tool only in the hands of someone experienced with cutting.  Our breadth of expertise is the hand that guides our cutting edge therapies."

Matt Kalaycio, MD

Director, Chronic Leukemia and Myeloma Program, Department of Hemotologic Oncology and Blood Disorders

“Active research in anti-cancer drug discovery and development, combined with further refinement of treatment delivery approaches, will continue to improve our level of service and the resulting outcomes.”

Derek Raghavan, MD, PhD

Chairman, Taussig Cancer Institute Chairman, Cancer Division, Cleveland Clinic

• Isolation of serotonin, a key factor in hypertension (1940s)• Development of “no-touch” colorectal surgery (1950s)• First coronary angiography (1958)• Development and refinement of coronary bypass surgery (1967)• First minimally invasive aortic heart valve surgery (1996)• First successful larynx transplant (1999)• Discovery of first gene linked to juvenile macular degeneration (2000)• Discovery of first gene linked to coronary artery disease (2003)• World’s first use of surgical robot for spinal surgery (2005)• First minimally invasive combined mitral valve surgery and ablation of atrial

fibrillation (2006)• Pioneered the use of deep brain stimulation to successfully treat profound

depression, Tourette syndrome and OCD (2006)

Numerous other breakthroughs and innovations have happened at Cleveland Clinic in fields ranging from basic science to brain surgery.

Cleveland Clinic Innovations

“Cleveland Clinic’s Lerner Research Institute is one of three NHLBI-funded Specialized Centers for Clinically Oriented Research (SCCOR) in Thrombosis. 

We are excited about the progress to date and are anticipating many clinically significant discoveries.”

Roy L. Silverstein, MD

Chair, Department of Cell Biology Cleveland Clinic Lerner Research Institute

Cleveland Clinic Annual Statistics

Patient Care3,458,509. . . Total Visits163,000 . . . . Admissions112,000 . . . . Surgical Cases1,808 . . . . . . Physicians and ScientistsEducation1,170 . . . . . . Residents and Fellows 624 . . . . . . . .Medical StudentsResearch$244M . . . . Total Research Funding

“Treating patients with stage IV head and neck cancer is challenging because of their poor prognosis and difficult tolerance, but the combined chemoradiotherapy approach offers excellent survival and organ preservation.”

Jerrold Saxton, MD

Department of Radiation Oncology